WO2000059897A3 - Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds - Google Patents
Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds Download PDFInfo
- Publication number
- WO2000059897A3 WO2000059897A3 PCT/EP2000/002850 EP0002850W WO0059897A3 WO 2000059897 A3 WO2000059897 A3 WO 2000059897A3 EP 0002850 W EP0002850 W EP 0002850W WO 0059897 A3 WO0059897 A3 WO 0059897A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ester
- hydroxyphenyl
- carbonates
- hydroxy
- esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU39644/00A AU3964400A (en) | 1999-04-06 | 2000-03-31 | Selective estrogenic compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99201071 | 1999-04-06 | ||
NL99201071.0 | 1999-04-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000059897A2 WO2000059897A2 (en) | 2000-10-12 |
WO2000059897A3 true WO2000059897A3 (en) | 2001-04-05 |
Family
ID=8240067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/002850 WO2000059897A2 (en) | 1999-04-06 | 2000-03-31 | Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3964400A (en) |
WO (1) | WO2000059897A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1165184E (en) * | 1999-04-09 | 2004-04-30 | Karobio Ab | ANTAGONISM OF ESTROGEN'S RECEPTOR-BETA AND BONES DISEASES |
UA83620C2 (en) | 2001-12-05 | 2008-08-11 | Уайт | Substituted benzoxazoles and analogues as estrogenic agents |
US6884814B2 (en) | 2001-12-13 | 2005-04-26 | Wyeth | Phenyl benzisoxazoles as estrogenic agents |
US6835745B2 (en) | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
AU2005282554A1 (en) | 2004-09-07 | 2006-03-16 | Wyeth | 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0729956A1 (en) * | 1995-02-28 | 1996-09-04 | Eli Lilly And Company | Benzothiophene compounds, intermediates, compositions, and methods |
EP0832888A1 (en) * | 1996-09-27 | 1998-04-01 | Eli Lilly And Company | Benzothiophene compounds, compositions, and methods |
US5760030A (en) * | 1997-06-30 | 1998-06-02 | Eli Lilly And Company | Benzothiophene compounds and methods of use |
US5843940A (en) * | 1996-10-24 | 1998-12-01 | Eli Lilly And Company | Benzothiophene compounds, compositions, and method |
WO1998056812A2 (en) * | 1997-06-10 | 1998-12-17 | Karo Bio Ab | Estrogen receptor crystals and ligands |
EP0963981A1 (en) * | 1998-06-12 | 1999-12-15 | Galderma Research & Development, S.N.C. | Biaryl heterocyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof |
-
2000
- 2000-03-31 WO PCT/EP2000/002850 patent/WO2000059897A2/en active Search and Examination
- 2000-03-31 AU AU39644/00A patent/AU3964400A/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0729956A1 (en) * | 1995-02-28 | 1996-09-04 | Eli Lilly And Company | Benzothiophene compounds, intermediates, compositions, and methods |
EP0832888A1 (en) * | 1996-09-27 | 1998-04-01 | Eli Lilly And Company | Benzothiophene compounds, compositions, and methods |
US5843940A (en) * | 1996-10-24 | 1998-12-01 | Eli Lilly And Company | Benzothiophene compounds, compositions, and method |
WO1998056812A2 (en) * | 1997-06-10 | 1998-12-17 | Karo Bio Ab | Estrogen receptor crystals and ligands |
US5760030A (en) * | 1997-06-30 | 1998-06-02 | Eli Lilly And Company | Benzothiophene compounds and methods of use |
EP0963981A1 (en) * | 1998-06-12 | 1999-12-15 | Galderma Research & Development, S.N.C. | Biaryl heterocyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
AU3964400A (en) | 2000-10-23 |
WO2000059897A2 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100246A (en) | Novel ester derivatives of substituted phenylcyclohexyl compounds | |
ZA200202947B (en) | Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof. | |
DK1176195T3 (en) | Method for controlling the activity of immunologically functional molecule | |
CA2360557A1 (en) | Biodegradable and thermosensitive polyphosphazenes and their preparation method | |
HK1043792A1 (en) | Quinoline derivatives and quinazoline derivatives. | |
NO985293D0 (en) | New 2,3-disubstituted-4 (3H) -quinazolinones | |
NO20100667L (en) | Process for the preparation of intermediates of benzoxazine derivatives | |
IT1319999B1 (en) | ASSEMBLY GROUP FOR SLIDING SLING-TONGUE OF A LAMPO HINGE. | |
WO1999000373A8 (en) | Benzimidazole derivatives | |
WO2000059897A3 (en) | Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds | |
WO2000005214A3 (en) | Isoquinolines as urokinase inhibitors | |
AU4787797A (en) | Thienylcyclohexanone derivatives as ligands of the gabaa alpha5 receptor subtype | |
BR0209901A (en) | Processes for the synthesis of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline derivatives | |
FI922308A0 (en) | SUBSTITUERADE OXOFTALAZINYLAETTIKS- SYROR OCH DERAS ANALOGER. | |
FR2794169B1 (en) | METHOD FOR CONTROLLING THE OPERATING CAPABILITY OF A CATALYTIC POT | |
HK1031867A1 (en) | 2-phenoxyaniline derivatives | |
DZ2607A1 (en) | Process for the synthesis of pharmaceutically active quinoline derivatives. | |
EP1231215A4 (en) | Process for the production of aspartyldipeptide ester derivatives, novel intermediates therefor and process for the production of the intermediates | |
HUP0103241A3 (en) | New process for the synthesis of (1h)-benzo[c]quinolizin-3-ones derivatives | |
DE60009319D1 (en) | SUBSTITUTED N-PHENYL-2-HYDROXY-2-METHYL-3,3,3-TRIFLUORPROPANAMIDE DERIVATIVE FOR INCREASING PYRUVATE DEHYDROGENASE ACTIVITY | |
AU1394397A (en) | Pyridine derivatives as fungicides | |
IL124226A (en) | Preparation of methyl 2-(2-methylphenyl)-3-methoxyacrylate by methoxymethylenation of methyl 2-methylphenylacetate | |
AU6721000A (en) | Synthesis of 3-ethoxy-4-ethoxycarbonyl phenyl acetic acid, key acid synthon ofrepaglinide | |
WO2001004123A3 (en) | Peroxide-based antimalarial compounds | |
DK1151130T3 (en) | Coenzyme useful for synthesis of L-carnitine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |